Predicting events in clinical trials using two time-to-event outcomes

被引:0
|
作者
Mu, Rongji [1 ,2 ]
Xu, Jin [1 ]
机构
[1] East China Normal Univ, Sch Stat, Shanghai 200241, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
基金
中国国家自然科学基金;
关键词
change point; convolution; event prediction; overall survival; progression-free survival; PROGRESSION-FREE SURVIVAL; SURROGATE; HAZARD; MODEL; ASSOCIATION; DEPENDENCE;
D O I
10.1002/bimj.201700083
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In clinical trials with time-to-event outcomes, it is of interest to predict when a prespecified number of events can be reached. Interim analysis is conducted to estimate the underlying survival function. When another correlated time-to-event endpoint is available, both outcome variables can be used to improve estimation efficiency. In this paper, we propose to use the convolution of two time-to-event variables to estimate the survival function of interest. Propositions and examples are provided based on exponential models that accommodate possible change points. We further propose a new estimation equation about the expected time that exploits the relationship of two endpoints. Simulations and the analysis of real data show that the proposed methods with bivariate information yield significant improvement in prediction over that of the univariate method.
引用
收藏
页码:815 / 826
页数:12
相关论文
共 50 条
  • [41] Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trials
    Weir, Isabelle R.
    Rider, Jennifer R.
    Trinquart, Ludovic
    PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 163 - 175
  • [42] Confirmatory Adaptive Designs for Clinical Trials With Multiple Time-to-Event Outcomes in Multi-state Markov Models
    Danzer, Moritz Fabian
    Faldum, Andreas
    Simon, Thorsten
    Hero, Barbara
    Schmidt, Rene
    BIOMETRICAL JOURNAL, 2024, 66 (07)
  • [43] Hybridization of conditional and predictive power for futility assessment in sequential clinical trials with time-to-event outcomes: A resampling approach
    Yi, Jing
    Fang, Liang
    Su, Zheng
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (01) : 138 - 142
  • [44] The net benefit for time-to-event outcome in oncology clinical trials with treatment switching
    Fukuda, Musashi
    Sakamaki, Kentaro
    Oba, Koji
    CLINICAL TRIALS, 2023, 20 (06) : 670 - 680
  • [45] LEVERAGING REAL-WORLD DATA FOR TIME-TO-EVENT ENDPOINTS IN CLINICAL TRIALS
    Parashar, D.
    Almgren, P.
    Berglund, A.
    Guasconi, A.
    Smith, C.
    Torlinska, B.
    Wang, J.
    Wang, Q.
    VALUE IN HEALTH, 2022, 25 (01) : S256 - S256
  • [46] A combined test for a generalized treatment effect in clinical trials with a time-to-event outcome
    Royston, Patrick
    STATA JOURNAL, 2017, 17 (02): : 405 - 421
  • [47] Bayesian Design of Clinical Trials Using Joint Cure Rate Models for Longitudinal and Time-to-Event Data
    Jiawei Xu
    Matthew A. Psioda
    Joseph G. Ibrahim
    Lifetime Data Analysis, 2023, 29 : 213 - 233
  • [48] Bayesian design of multi-regional clinical trials with time-to-event endpoints
    Bean, Nathan William
    Ibrahim, Joseph George
    Psioda, Matthew Austin
    BIOMETRICS, 2023, 79 (04) : 3586 - 3598
  • [49] Bayesian Design of Clinical Trials Using Joint Cure Rate Models for Longitudinal and Time-to-Event Data
    Xu, Jiawei
    Psioda, Matthew A.
    Ibrahim, Joseph G.
    LIFETIME DATA ANALYSIS, 2023, 29 (01) : 213 - 233
  • [50] Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes
    Crisp, Amy M.
    Halloran, M. Elizabeth
    Hitchings, Matt D. T.
    Longini, Ira M.
    Dean, Natalie E.
    BMC MEDICAL RESEARCH METHODOLOGY, 2025, 25 (01)